Oritavancin
CAS: 171099-57-3
Ref. 3D-AA16180
| 1mg | 163.00 € | ||
| 2mg | 238.00 € | ||
| 5mg | 457.00 € | ||
| 10mg | 651.00 € | ||
| 25mg | 1,126.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Product Information
Name:
Oritavancin
Synonyms:
- (4R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-a-L-arabinohexopyranosyl)-N3-(p-(p-chlorophenyl)benzyl)vancomycin
- (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3''-(4'-chloro[1,1'-biphenyl]-4-ylmethyl)vancomycin
- Ly-333328
- Orbactiv
- Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-<span class="text-smallcaps">L</span>-arabino-hexopyranosyl)-N<sup>3′′</sup>-[(4′-chloro[1,1′-biphenyl]-4-yl)methyl]-, (4′′R)-
- Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-arabino-hexopyranosyl)-N3′′-[(4′-chloro[1,1′-biphenyl]-4-yl)methyl]-, (4′′R)-
Description:
Oritavancin is a semi-synthetic lipoglycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to the D-alanyl-D-alanine moiety of peptidoglycan precursors. It has been shown to be active against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens. Oritavancin also inhibits the growth of thp-1 cells in vitro and has been shown to be effective against endocarditis caused by MRSA.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
1,793.1 g/mol
Formula:
C86H97Cl3N10O26
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-AA16180 Oritavancin
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
